@misc{KuenzelRauschSchaefferetal., author = {K{\"u}nzel, Stephan R. and Rausch, Johanna S. E. and Sch{\"a}ffer, Charlotte and Hoffmann, Maximilian and K{\"u}nzel, Karolina and Klapproth, Erik and Kant, Theresa and Herzog, Natalie and K{\"u}pper, Jan-Heiner and Lorenz, Kristina and Dudek, Svenja and Emig, Ramona and Ravens, Ursula and Rog-Zielinska, Eva A. and Peyronnet, R{\´e}mi and El-Armouche, Ali}, title = {Modeling atrial fibrosis in vitro - Generation and characterization of a novel human atrial fibroblast cell line}, series = {FEBS Open Bio}, volume = {10}, journal = {FEBS Open Bio}, number = {7}, issn = {2211-5463}, doi = {10.1002/2211-5463.12896}, pages = {1210 -- 1218}, abstract = {Atrial fibrillation (AF) is regularly accompanied by cardiac fibrosis and concomitant heart failure. Due to the heterogeneous nature and complexity of fibrosis, the knowledge about the underlying mechanisms is limited, which prevents effective pharmacotherapy. A deeper understanding of cardiac fibroblasts is essential to meet this need. We previously described phenotypic and functional differences between atrial fibroblasts from patients in sinus rhythm and with AF. Herein, we established and characterized a novel human atrial fibroblast line, which displays typical fibroblast morphology and function comparable to primary cells but with improved proliferation capacity and low spontaneous myofibroblast differentiation. These traits make our model suitable for the study of fibrosis mechanisms and for drug screening aimed at developing effective antifibrotic pharmacotherapy.}, language = {en} }